Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S , Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E
The medication's impact on the brain extends beyond metabolism
After reviewing studies and patient data, researchers found that people with Type 2 diabetes taking semaglutide may have about twice the risk of developing NAION compared to those not taking the drug
A higher intake of vitamin B2 (quartile 4) was significantly correlated with decreased risk of reduced femoral BMD levels, with the being 0.020 (95%CI: 0.0070.033), 0.015 (95%CI: 0.0020.027), 0.020 (95%CI: 0.0090.031) and 0.022 (95%CI: 0.0060.037) for the BMD of total femur, femoral neck, trochanter, and intertrochanter, respectively (all P value 65 years) again
Not NutraBio LeanShots L-Carnitine 3000
Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia
